[1] |
LIU Xiumei, GUO Qianqian, FANG Yuan, CHEN Nan, QI Qi.
Pharmaceutical care of patients with antithrombotic therapy after transjugular intrahepatic portal shunt
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 556-560.
|
[2] |
ZHANG Zhaowei, LI Zuojun, HUANG Jian, LI Shuangqing, HE YiLin.
Exploring the outbreak point for clinical pharmacists to provide pharmaceutical care in nephrology department
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 184-188.
|
[3] |
WU Yuanzhu, LIU Jun, YANG Kui, PENG Jing, LUAN Jiajie, WEI Jun, ZHANG Dafa, SONG Shuai, YUAN Xiaolong, WANG Zhongfang, ZHANG Nianbao, XIE Dan, JIANG Peng, FAN Jie.
Distribution of CYP2C9*3 and VKORC1-1639G>A gene polymorphism in Anhui Han population and their influence on the stable dose of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 652-659.
|
[4] |
LIAN Jinfang, LIU Yiwei, LIN Cuihong, HUANG Pinfang, LIN Rongfang.
Comparison of prediction accuracy between warfarin PPK/PD model and multiple regression dose models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 267-273.
|
[5] |
ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng.
Model informed precision dosing of warfarin: China expert consensus report (2022 version)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.
|
[6] |
WEN Dusu, WANG Yi, SUN Jianjun.
Comparison of Bayesian method and multiple linear regression method in predicting warfarin dose model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 33-38.
|
[7] |
ZHAI Yu, YANG Jin.
Effects of dietary vitamin K on the stability of warfarin anticoagulation therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 709-715.
|
[8] |
YANG Bo, SHI Dawei, ZHENG Zaoqian.
Pharmaceutical care on one case of hypobrinogenemia induced by hemocoagulase
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 932-936.
|
[9] |
LI Jingjing, YU Yanxia, TANG Lian, ZHANG Jinkun, YU Qiang, SHANG Erning.
Influence of clinical pharmaceutical care on medication compliance and treatment effect in Helicobacter pylori positive peptic ulcer outpatients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 199-204.
|
[10] |
ZHU Xuting, HANG Yongfu.
Clinical pharmacists' pharmaceutical care and practice in the department of nephrology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1174-1178.
|
[11] |
WANG Shiqi, HU Huawen, CHEN Xiaomin, WANG Jian, YE Honghua.
Effects of different intensities of warfarin on patients with coronary atherosclerotic heart disease complicated with atrial fibrillation: a comparative study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1410-1414.
|
[12] |
YANG Rui, XU Haisha, ZHANG Zanling, QU Jian, LI Juan, PENG Shiqi, DAI Yuxin, QU Qiang.
Effect of drug interaction on anticoagulant strength of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1426-1431.
|
[13] |
LI Haigang, FAN Rong, MA Ning, TANG Jing, LIAO Hongchun, ZHENG Xiahui.
Research progress on pharmacokinetics factors of warfarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1292-1298.
|
[14] |
LI Lin, ZHANG WEI, SHEN Chen-lin, ZHANG Ping, HUANG Xiao-hui.
Study of drug interaction between aspirin and warfarin in situ intestinal absorption model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 486-492.
|
[15] |
HU Jing, ZHU Jun-rong, YU Feng.
Efficacy and safety of warfarin dosage algorithms in clinical application:A Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 296-303.
|